|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
In skeletal muscle fibers, nitric oxide (NO) is synthesized by neuronal NO synthase (nNOS) and regulates excitation-contraction coupling, glucose uptake, and mitochondrial respiration. Recently, a novel 89-amino acid protein, designated protein inhibitor of nNOS (PIN), has been shown to interact with and specifically inhibit nNOS activity. In this study, we investigated the distribution, localization, and regulation of PIN expression in ventilatory and limb muscles of various species. Amplified PIN cDNA from the rat diaphragm revealed an open reading frame identical to that of human PIN. Among muscles of adult rats, PIN mRNA was strongly expressed in muscles rich in type I fibers, whereas much weaker expression was evident in muscles rich in type II fibers. By comparison, PIN protein expression was not related to fiber-type distribution. Similarly, PIN protein was equally expressed among rat, mouse, and human diaphragms. Both PIN mRNA and PIN protein were expressed at much higher levels in the embryonic rat diaphragm than in adult muscle. Immunohistochemistry revealed that PIN protein was localized in close proximity to the sarcolemma and nuclei. PIN protein was also abundant in muscle spindles and axons of nerves supplying skeletal muscle fibers. We conclude that PIN is expressed in various skeletal muscle fibers and that its expression is regulated during muscle development. The localization of PIN in muscle regions containing abundant nNOS protein suggests that it plays a role in the regulation of NO synthesis in skeletal muscle fibers.
| |
Introduction |
|---|
|
|
|---|
Nitric oxide (NO), a second messenger with numerous biologic functions, is synthesized by a group of flavoproteins known as nitric oxide synthases (NOS). Three NOS isoforms, endothelial cell (ecNOS), neuronal (nNOS), and inducible NOS, have been cloned so far. In normal skeletal muscle fibers, NO modulates a wide range of processes, including glucose uptake, excitation-contraction coupling, Ca2+ homeostasis, sarcolemmal ionic pumps, mitochondrial respiration, and neuromuscular transmission (1). NO also plays a significant role in the maturation of skeletal muscle in vivo (5) and regulates the fusion of cultured myoblasts in vitro (6). nNOS, the main NOS isoform responsible for NO synthesis in normal muscle fibers, is localized beneath the sarcolemma of mainly fast-twitch fibers (4). The association of nNOS with the sarcolemma is mediated through its interaction with the dystrophin complex. Disruption of the dystrophin complex in Duchenne and Becker muscular dystrophies results in downregulation of nNOS expression (7, 8) as well as displacement of nNOS from the sarcolemma to the cytoplasm.
Jaffrey and Snyder (9) used yeast two-hybrid screening of the rat hippocampal cDNA library to identify a small (89-amino acid) protein designated protein inhibitor of nNOS (PIN). This protein selectively associates with residues 163 to 245 of nNOS and destabilizes the nNOS dimer, thereby inhibiting nNOS activity. Recent studies indicate that PIN mRNA and protein are highly expressed in the brain and testes of normal humans (10). Amino acid sequencing of PIN suggests that it is one of the most conserved proteins in nature, with a high homology to the light-chain component of dynein in Drosophila (10), C. elegans (11), and Chlamydomonas (12). Dyneins are highly complex molecular microtubule-based motors responsible for retrograde translocation of membranous vesicles along microtubules. The critical importance of PIN as a component of cytoplasmic dynein was demonstrated recently in Drosophila in which partial loss-of-function mutations in PIN protein were associated with morphogenetic defects in bristle and wing development (10).
Despite the recent discovery of PIN as an endogenous regulator of nNOS activity, little is known about its expression and regulation in normal muscle fibers. The main aim of this study was therefore to investigate whether PIN is expressed in various ventilatory and limb muscle fibers and whether its expression is regulated in a fashion similar to that of nNOS. We also assessed whether PIN associates with the dynein complex inside skeletal muscle fibers.
| |
Materials and Methods |
|---|
|
|
|---|
Reagents
Western blotting apparatus and gels were obtained from Novex Inc. (San Diego, CA). Monoclonal anti-nNOS antibody was supplied by Transduction Laboratories (Lexington, KY). Affinity-purified polyclonal anti-PIN antibody was raised in rabbits by injecting histidine-tagged recombinant PIN, and purification was achieved with the glutathione-S-transferase (GST)-PIN column (9). Enhanced chemiluminescence (ECL) detection kits and nylon membranes were purchased from Amersham Canada (Oakville, ON, Canada). One hundred base-pair DNA markers and reverse transcriptase were procured from Life Technologies, Inc. (Gaithersburg, MD). A TA cloning kit was provided by Invitrogen, Inc. (San Diego, CA). Cy3-labeled secondary antibody was obtained from Jackson ImmunoResearch, Inc. (West Grove, PA).
Tissue Preparation
Rats.
Pathogen-free Sprague-Dawley rats (250-350 g)
were killed by decapitation, and the cerebellum, diaphragm, intercostal, gastrocnemius, tibialis anterior, and
soleus muscles were quickly excised and frozen in liquid
nitrogen. For immunostaining, the tissues were first flash-frozen in cold isopentane (20 s), then immersed in liquid
nitrogen and stored at
80°C. To assess the regulation of
PIN expression during in vivo muscle development, six
pathogen-free, time-dated, pregnant Sprague-Dawley rats
obtained from Charles River Laboratories (St. Constant,
PQ, Canada) were killed at the gestational age of 18 d
(E-18), and diaphragms from their fetuses were quickly
dissected and frozen in liquid nitrogen. Diaphragms from
littermate fetuses were pooled.
Mice.
Five-week-old C57/B6 mice (Charles River Laboratories) were killed by sodium pentobarbital overdose,
and their diaphragms were excised, quickly frozen in liquid nitrogen, and stored at
80°C.
Human.
Proper ethical approval was obtained for human experimentation. Tissue samples were obtained from
the sternal region of the diaphragm of adult patients undergoing cardiac transplantation. Small portions of the diaphragm were quickly frozen and stored at
80°C.
RNA Isolation and Reverse Transcription-Polymerase Chain Reaction
Total RNA was isolated from different tissues by the method of Chomczynski and Sacchi (13). For cloning of the PIN coding sequence, total RNA (1 µg) from rat diaphragms was reverse transcribed by using random primers and Maloney murine leukemia virus reverse transcriptase. Polymerase chain reaction (PCR) amplification of the PIN coding sequence was accomplished by forward primer 5'-ATGTGCGACCGAAAGGCCGTAGATC-3' and reverse primer 5'-TTAACCAGATTTGAACAGAAGAATGGCC-3'. PCR was carried out at 94°C for 30 s, 50°C for 30 s, and 72°C for 30 s for a total of 30 cycles. The resultant cDNA was subjected to electrophoresis in 2% agarose gel and visualized by ethidium bromide staining. The appropriate size DNA fragment was excised, ligated into cloning vector pCRII.1, and then sequenced (McGill University automated DNA sequence facility).
Northern Blotting
Total RNA (30 µg) was mixed with 1 µl of 10 µg/µl ethidium bromide and separated by electrophoresis on 1.5%
agarose gels containing 2.2 M formaldehyde. The RNA
was then transferred to nylon membranes and rRNA was
visualized under ultraviolet light and photographed to verify that equal amounts of RNA were loaded on all lanes. The membranes were then challenged with randomly
primed 270-bp 32P-labeled PIN cDNA recently amplified
from rat tissues (14). The blots were washed in 0.2× standard saline citrate and 0.2% sodium dodecyl sulfate (SDS)
for 10 min at room temperature, then at 65°C for 1 h. The
membranes were exposed to X-ray film using an intensifying screen at
70°C.
Immunoblotting
Frozen tissues were homogenized in 6 vol (wt/vol) of homogenization buffer (pH 7.4, 10 mM N-2-hydroxyethyl-piperazine-N'-ethanesulfonic acid buffer, 0.1 mM ethylenediaminetetraacetic acid [EDTA], 1 mM dithiotreitol, 1 mg/ml phenylmethylsulfonyl fluoride [PMSF], 0.32 mM sucrose, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 10 µg/ml pepstatin A, and 1% Triton X-100). The crude homogenates were centrifuged at 4°C for 15 min at 8,000 × g. The supernatants (80 µg total protein) were heated for 15 min at 90°C and then loaded on 18% Tris-glycine SDS-polyacrylamide gels. Proteins were electrophoretically transferred onto polyvinylidene difluoride membranes, blocked with 5% nonfat dry milk, and subsequently incubated with either affinity-purified anti-PIN antibody (1:500) or monoclonal anti-nNOS (1:1,000) antibody. Recombinant PIN protein expressed as GST-fusion protein in E. coli (9) and pituitary lysate were respectively used as positive controls. Specific proteins were detected with horseradish peroxidase-conjugated antimouse secondary antibody and ECL reagents. The blots were scanned with an imaging densitometer (Model GS700, 12-bit precision and 42-µm resolution; Bio-Rad Inc., Hercules, CA), and optical densities of the protein bands were quantified with SigmaGel software (Jandel Scientific, San Rafael, CA). Predetermined molecular weight standards were used as markers. Protein concentration was measured by the Bradford method with bovine serum albumin as the standard.
Immunoprecipitation
To investigate whether PIN associates with the cytoplasmic dynein complex, we immunoprecipitated cytoplasmic dynein using an antibody raised against the 74-kD intermediate chain subunit of mammalian dynein (IC74) (15). Adult rat gastrocnemius muscles were homogenized in Triton X-100 lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 0.02% NaN3, 0.05% Triton X-100, 2 mM EDTA, 1 mg/ml PMSF, 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 10 µg/ml pepstatin, pH 7.4). The homogenate was spun at 27,000 × g for 15 min and the supernatant was recovered, respun, and then incubated with monoclonal anti-IC74 antibody (10 µl/0.5 g tissue) (Chemicon Inc., Temecula, CA) for 2 h at 4°C. Protein A-agarose conjugate and secondary rabbit antimouse antibody were then added, and the samples were incubated for another hour. After centrifugation, the pellets were washed twice with a buffer containing 125 mM Tris-HCl, pH 8.1, 500 mM NaCl, 0.5% Triton X-100, 10 mM EDTA, and 0.02% NaN3. The final wash was performed with water. Proteins were eluted with electrophoresis sample buffer, and immunoblotting of supernatant and eluted proteins was undertaken as described. Membranes were probed with anti-IC74 and anti-PIN antibodies. Proper negative controls included omission of primary antibody and omission of protein A-agarose conjugate and secondary antibodies.
Immunohistochemistry
Air-dried cryostat sections (10 µm) were rehydrated with phosphate-buffered saline (PBS; pH 7.4, 3-5 min) and blocked for 1 h with normal donkey serum. The sections were then incubated overnight with either affinity-purified anti-PIN antibody (see above) or polyclonal anti-nNOS antibody (16). After three washes with saline PBS, the sections were incubated with Cy3-labeled donkey antirabbit secondary antibody. Slides were visualized with a Nikon fluorescence microscope (Melville, NY) and a Molecular Dynamics (Sunnyvale, CA) confocal argon laser scanning system equipped with a Cy3 filter. A similar protocol was used for negative control sections except that anti-PIN antibody was preincubated with recombinant PIN protein (9).
| |
Results |
|---|
|
|
|---|
Cloning of Rat PIN cDNA
Amplification of the mammalian PIN coding sequence from rat diaphragmatic RNA by reverse transcription- PCR produced a single 270-bp band. Sequencing of this band revealed an open reading frame of an 89-amino acid protein, which is 100% homologous to human dynein light chain 1 (10) (Figure 1).
|
Expression of PIN during Muscle Development
Figure 2 illustrates PIN mRNA (A) and protein (B) expression in embryonic and adult rat diaphragms. A major ~ 0.9-kb band was detected in both muscles, with embryonic expression more than 4-fold higher than in mature muscle (Figure 2A). In addition, a minor transcript of an equivalent size of 18 S ribosomal RNA was detected only in the embryonic diaphragm (filled triangle, Figure 2A). Probing the rat cerebellum with PIN cDNA revealed a major 0.9-kb transcript similar to that expressed in skeletal muscle and a minor 2.5-kb transcript that was not detected in skeletal muscle RNA (open triangle, Figure 2A). Immunoblotting of the rat cerebellum and embryonic and adult diaphragms with anti-PIN antibody revealed an ~ 8-kD band that was 2.5-fold more intense in the embryonic diaphragm than in mature muscle (Figure 2B). A similar protein band was detected in the cerebellum (Figure 2B).
|
Intra- and Interspecies Differences in PIN Expression
Figure 3 illustrates the differences in PIN mRNA (A) and protein (B) expressions between various muscles of adult rats. A strong 0.9-kb band was detected in the soleus muscle, whereas weaker expression was evident in the tibialis and gastrocnemius muscles (Figure 3A). Unlike PIN mRNA, PIN protein was expressed to a similar degree in various muscles of adult rats (Figure 3B). In addition to the 8-kD protein band, the anti-PIN antibody detected two additional bands with apparent masses of 13- and 22-kD (open arrows, Figure 3B). These bands were undetectable when anti-PIN antibody was preincubated with pure PIN protein (data not shown). Figure 4 illustrates the relationship between the intensity of PIN mRNA and protein expression and the percentage of type I fibers in various mature rat muscles (17). Although PIN mRNA expression correlated significantly and positively with the percentage of type I fibers (r = 0.93, P < 0.001), no correlation was found between PIN protein and the percentage of type I fibers. Figure 5 shows interspecies differences in diaphragmatic PIN protein expression. PIN protein was expressed to a similar degree in human, mouse, and rat diaphragms. By comparison, nNOS protein expression was more prominent in the human diaphragm than in rat and mouse diaphragms (Figure 5).
|
|
|
Localization of PIN Protein
Immunostaining of the adult rat diaphragm (Figure 6A) and soleus (Figure 6B) muscles with anti-PIN antibody revealed positive staining in close proximity to the sarcolemma and the nuclei. Faint cytoplasmic staining was also evident in a few muscle fibers (Figure 6). Strong, positive PIN staining was also detected in muscle spindles (Figure 7B) and in the axons of nerve fibers supplying skeletal muscles (Figure 7A). No staining was evident when PIN antibody was preadsorbed with pure PIN protein (data not shown).
|
|
Association of PIN with the Dynein Complex
Cytoplasmic dynein in gastrocnemius muscle homogenates was immunoprecipitated with anti-IC74 antibody. Figure 8 reveals that PIN protein was immunoprecipitated by anti-IC74 antibody, indicating that PIN associates with the dynein complex in skeletal muscles. It should also be emphasized that PIN protein was still detectable in the supernatant, suggesting that not all PIN protein molecules associate with IC74 protein.
|
| |
Discussion |
|---|
|
|
|---|
The main findings of this study are (1) PIN mRNA and protein are expressed in skeletal muscle fibers of various species; (2) significantly higher levels of PIN mRNA and protein are expressed in embryonic muscles than in adult muscles; (3) PIN protein is localized at several sites, including the sarcolemma and nuclei of muscle fibers, nerves supplying muscle fibers, and muscle spindles.
Discovery of PIN
Since the independent discovery of PIN in mammalian
cells by several groups (9, 10, 18), diverse proteins have
been found to interact and associate with PIN. These include flagellar dynein (12), cytosolic dynein (18), nNOS
(9), myosin V (19), and I
B
(20). In addition, PIN appears to be essential for normal development in Drosophila as loss-of-function mutations of the drosophila
PIN homolog are lethal (10). It is unclear whether this
phenotype in Drosophila reflects an essential role for PIN
in the normal function of dynein, myosin V, I
B
, nNOS, or some other, as yet unidentified, PIN-binding protein. In
relation to NO production, it has been shown that PIN interacts specifically with the N-terminal part of nNOS and
inhibits nNOS selectively by preventing the dimerization
of nNOS monomers (9). Our group has confirmed recently
that nNOS protein interacts directly with PIN (14). We
also reported that PIN protein is expressed to differing degrees in various regions of the rat brain (14).
Significant progress has been made recently in elucidating the role of PIN as a component of dynein, which is a multisubunit enzyme complex responsible for retrograde axonal transport, nuclear migration, and movement of organelles such as lysosomes, chromosomes, and the Golgi apparatus. Many subunits of dynein have been cloned, including heavy, intermediate, light intermediate, and light chains (21). Unlike heavy and intermediate chains, the nature, localization, and functional significance of light intermediate and light chains in mammalian cells are not yet clear. An Mr 8,000 mammalian homolog of Drosophila and flagellar dynein light chains with an identical amino acid sequence to PIN have been cloned recently from rat and bovine brains (18). In oligodentrocytes, this protein is localized at the cell periphery and colocalizes with cytoplasmic dynein. This finding confirmed that PIN and Mr 8,000 are the same protein and that PIN is an important component of the dynein complex.
Little is known about the existence, functional significance, and localization of the dynein complex in skeletal muscle fibers. Yoshida and colleagues (22) described abundant heavy-chain dynein expression in muscle spindles with no evidence of positive immunostaining in muscle fibers. In a separate study, Paschal and coworkers (23) reported that various rat tissues, including skeletal muscles, express significant levels of the 74-kD intermediate chain of dynein. Our results indicate for the first time that PIN is ubiquitously expressed in skeletal muscle fibers of various species. More importantly, we found that PIN protein is localized in distinct compartments inside and outside skeletal muscle fibers, namely, the sarcolemma, muscle spindles, and nerves supplying muscle fibers. The fact that these sites also contain abundant nNOS expression suggests that PIN is likely to play a role in regulating nNOS activity in these sites. In addition, the association of PIN with IC74 in muscle homogenates (Figure 8) suggests that PIN may also exist as a component of the dynein complex. Taken together, the localization of PIN in different sites inside muscle fibers suggests the existence of more than one intracellular pool of PIN. In mammalian brains, King and colleagues (18) identified at least three biochemically distinct pools of PIN: (1) non-microtubule-associated; (2) microtubule-associated and eluted with adenosine triphosphate and salt (component of the dynein complex); and (3) microtubule-associated but not salt-extractable (18). The finding of a portion of PIN immunoprecipitates with the dynein complex (Figure 8) supports the notion that distinct pools of PIN exist in skeletal muscle fibers.
Little information is available regarding the changes in dynein complex expression during development. In Drosophila, only the 4.5-kb mRNA transcript of dynein light chain 1 is regulated during embryonic development, whereas the main 2.4-kb transcript remains ubiquitously expressed (10). In mammals, expression of the 74-kD intermediate chain of cytoplasmic dynein is relatively constant during brain development, suggesting that the cytoplasmic dynein level is not developmentally regulated. Our study shows for the first time that PIN mRNA and proteins undergo significant developmental regulation (Figure 2). Although we did not investigate the regulation of various intracellular pools of PIN during muscle development, it is likely that the higher level of PIN detected in embryonic muscle fibers is a reflection of a greater requirement for dynein activity in the developing muscle fiber. In addition to being a component of the cytoplasmic dynein complex, PIN expression in the embryonic diaphragm is likely to play an important role in regulating the augmented nNOS activity recently described by our group (5).
Our results also indicate that the distribution of PIN mRNA in various rat skeletal muscles does not relate to the profile of PIN protein expression (Figures 3 and 4). It is possible that post-transcriptional and/or post-translational mechanisms are involved in the disparity between PIN mRNA and protein expression. One of these possible mechanisms is mRNA stability. It is likely that the stability of PIN mRNA varies in different skeletal muscle fibers. Differences in the PIN mRNA transcription rate between various muscles are also likely. Finally, post-translational modifications such as phosphorylation are likely to influence PIN protein degradation and thus impact on PIN protein levels in different muscle fibers. However, we believe that, unlike IC74, which is phosphorylated in glial and cultured neurons (24), PIN protein does not undergo major post-translational changes in mammalian cells because pure bacterially produced PIN (obtained by cleaving purified GST-PIN fusion protein at the GST-PIN junction with Factor Xa protease) migrated with the same apparent molecular mass as the mammalian PIN found in skeletal muscles and the cerebellum (Figure 2). Clearly, more detailed studies are needed to establish the exact mechanisms responsible for the regulation of PIN protein expression in mammalian cells.
NO Production in Skeletal Muscles
It has been well established that NO is synthesized inside
skeletal muscle fibers by the nNOS isoform (4, 25). This
isoform is localized at the junctional and extrajunctional
sarcolemma and muscle spindles. Localization of nNOS to
these compartments is accomplished through direct interaction between nNOS and the
-1 syntrophin component
of the dystrophin complex (26). However, the dissociation
between nNOS expression and that of dystrophin and
-1
syntrophin after denervation or in patients with muscular dystrophies (8, 27) suggests the existence of as yet unidentified molecules that are involved in anchoring nNOS to
subcellular compartments of skeletal muscle fibers. Our
main finding of abundant PIN expression in close proximity to the sarcolemma raises an intriguing possibility that
PIN may be involved not only in regulating nNOS activity but also in anchoring nNOS protein to the sarcolemma. If
this is true, PIN would function in a fashion similar to caveolin-1 and caveolin-3 in endothelial cells and skeletal
muscle fibers. Recent studies indicate that ecNOS protein
is anchored to endothelial cell membranes through an inhibitory heteromeric complex with caveolin-1 (28). This complex serves not only to anchor ecNOS to the cell membranes but regulates ecNOS activity as well. Similarly, there
is evidence that nNOS protein associates with caveolin-3 in skeletal muscle fibers (29). It is therefore possible that PIN is involved in anchoring nNOS to membrane-associated proteins and regulating nNOS activity by directly inhibiting the formation of nNOS dimers. Moreover, the existence of PIN inside muscle fibers signifies the possible
involvement of this protein in the regulation of various
processes that are normally modulated by endogenous nNOS activity. These processes include excitation-contraction coupling, glucose uptake, mitochondrial respiration,
and neuromuscular transmission.
In summary, our study indicates for the first time that PIN, the endogenous regulator of nNOS activity, is abundantly expressed in skeletal muscle fibers of various species and that it is regulated during skeletal muscle development. We also found that PIN is localized in distinct compartments, which include the sarcolemma, nucleus, muscle spindles, and nerve fibers supplying skeletal muscles.
| |
Footnotes |
|---|
Abbreviations: endothelial cell nitric oxide synthase, ecNOS; ethylene diamine tetraacetic acid, EDTA; glutathione-S-transferase, GST; 74-kD intermediate chain subunit of mammalian dynein, IC74; nitric oxide, NO; neuronal nitric oxide synthase, nNOS; polymerase chain reaction, PCR; protein inhibitor of nNOS, PIN.
(Received in original form May 27, 1998).
Acknowledgments: This study is supported by a grant from the Medical Research Council of Canada. Dr. S. Hussain and Dr. M. Greenwood are scholars of Fonds de la recherche en santé du Québec.
| |
References |
|---|
|
|
|---|
1. Meszaros, L. G., I. Minarovic, and A. Zahradnikova. 1996. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 380: 49-52 [Medline].
2. Stoyanovsky, D., T. Murphy, P. R. Anno, Y. M. Kim, and G. Salama. 1997. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell. Calc. 21: 19-29 [Medline].
3.
Balon, T. W., and
J. L. Nadler.
1997.
Evidence that nitric oxide increases
glucose transport in skeletal muscle.
J. Appl. Physiol.
82:
359-363
4. Kobzik, L., M. B. Reid, D. S. Bredt, and J. S. Stamler. 1994. Nitric oxide in skeletal muscle. Nature 372: 546-548 [Medline].
5.
El-Dwairi, Q.,
Y. Guo,
A. Comtois,
E. Zhu,
M. E. Greenwood,
D. S. Bredt, and
S. N. A. Hussain.
1998.
Ontogenesis of nitric oxide synthase in the
ventilatory muscles.
Am. J. Respir. Cell Mol. Biol.
18:
844-852
6.
Lee, K. H.,
M. Y. Baek,
K. Y. Moon,
W. K. Song,
C. H. Chung,
D. B. Ha, and
M. Kang.
1994.
Nitric oxide as a messenger molecule for myoblast fusion.
J. Biol. Chem.
269:
14371-14374
7.
Chang, W.,
S. T. Iannaccone,
K. S. Lau,
B. S. S. Masters,
T. J. McCabe,
K. McMillan,
R. C. Padre,
M. J. Spencer,
J. G. Tidball, and
J. T. Stull.
1996.
Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.
Proc. Natl. Acad. Sci. USA
93:
9142-9147
8.
Chao, D. S.,
J. R. M. Gorospe,
J. E. Brenman,
J. A. Rafael,
M. F. Peters,
S. C. Froehner,
E. P. Hoffman,
J. S. Chamberlain, and
D. S. Bredt.
1996.
Selective loss of sarcolemmal nitric oxide synthase in Becker muscular
dystrophy.
J. Exp. Med.
184:
609-618
9.
Jaffrey, S. R., and
S. H. Snyder.
1996.
PIN: an associated protein inhibitor of
neuronal nitric oxide synthase.
Science
274:
774-777
10. Dick, T., K. Ray, H. K. Salz, and W. Chia. 1996. Cytoplasmic dynein (ddlcl) mutations cause morphogenetic defects and apoptotic cell death in Drosophila melanogaster. Mol. Cell. Biol. 16: 1966-1977 [Abstract].
11. Wilson, R., R. Ainscough, K. Anderson, C. Baynes, M. Berks, J. Bonfield, J. Burton, M. Connell, T. Copsey, and J. Cooper. 1994. 2.2 Mb of contiguous nucleotide sequence from chromone III of C. elegans. Nature 368: 32-38 [Medline].
12.
King, S. M., and
R. S. Patel-King.
1995.
The M(r) = 8,000 and 11,000 outer
arm dynein light chains from Chlamydomonas flagella have cytoplasmic
homologues.
J. Biol. Chem.
270:
11445-11452
13. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159 [Medline].
14. Greenwood, M. E., Y. Guo, U. Kumar, S. Beausejours, and S. N. A. Hussain. 1997. Distribution of protein inhibitor of neuronal nitric oxide synthase (PIN) in rat brain. Biochm. Biophys. Res. Commun. 238: 617-621 [Medline].
15.
Dillman, J. F. I., and
K. K. Pfister.
1994.
Differential phosphorylation in
vivo of cytoplasmic dynein associated with anterogradely moving organelles.
J. Cell Biol.
127:
1671-1681
16. Bredt, D. S., P. M. Hwang, and S. H. Snyder. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature Lond. 347: 768-770 [Medline].
17.
Delp, M. D., and
C. Duan.
1996.
Composition and size of type I, IIA, IID/X,
and IIB fibers and citrate synthase activity of rat muscle.
J. Appl. Physiol.
80:
261-270
18.
King, S. M.,
E. Barbarese,
J. F. I. Dillman,
R. S. Patel-King,
J. H. Carson, and
K. K. Pfister.
1996.
Brain cytoplasmic and flagellar outer arm dyneins share
a highly conserved Mr 8,000 light chain.
J. Biol. Chem.
271:
19358-19366
19. Espindola, F. S., R. E. Cheney, S. M. King, D. M. Suter, and M. S. Mooseker. 1996. Myosin V and dynein share a similar light chain. Mol. Biol. Cell 7: 372A . (Abstr.) .
20.
Crepieux, P.,
H. Kwon,
N. Leclerc,
W. Spencer,
S. Richard,
R. Lin, and
J. Hiscott.
1997.
I
B
physically interacts with a cytoskeleton-associated
protein through its signal response domain.
Mol. Cell. Biol.
17:
7375-7385
[Abstract].
21.
Vaughan, K. T., and
R. B. Vallee.
1995.
Cytoplasmic dynein binds dynactin
through a direct interaction between the intermediate chains and p150Glued.
J. Cell Biol.
131:
1507-1516
22.
Yoshida, T.,
H. Takanari, and
K. Izutsu.
1992.
Distribution of cytoplasmic
and axonemal dyenins in rat tissues.
J. Cell Sci.
101:
579-587
23.
Paschal, B. M.,
A. Mikami,
K. K. Pfister, and
R. B. Vallee.
1992.
Homology
of the 74-kDa cytoplasmic dynein subunit with a flagellar dynein polypeptide suggests an intracellular targeting function.
J. Cell Biol.
118:
1133-1143
24.
Pfister, K. K.,
M. W. Salata,
J. F. I. Dillman,
K. T. Vaughan,
R. B. Vallee,
E. Torre, and
R. J. Lye.
1996.
Differential expression and phosphorylation of
the 74-kDa intermediate chains of cytoplasmic dynein in cultured neurons
and glia.
J. Biol. Chem.
271:
1687-1694
25. Nakane, M., H. H. H. W. Schmidt, J. S. Pollock, U. Forstermann, and F. Murad. 1993. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 316: 175-180 [Medline].
26.
Brenman, J. E.,
D. S. Chao,
S. H. Gee,
A. W. McGee,
S. E. Craven,
D. R. Santillano,
Z. Wu,
F. Huang,
H. Xia,
M. F. Peters,
S. C. Froehner, and
D. S. Bredt.
1996.
Interaction of nitric oxide synthase with the postsynaptic
density protein PSD-95 and
1-syntrophin mediated by PDZ domains.
Cell
84:
757-767
[Medline].
27. Tews, D. S., H. H. Goebel, I. Schneider, A. Gunkel, E. Stennert, and W. F. Neiss. 1997. Expression of different isoforms of nitric oxide synthase in experimentally denervated and reinnervated skeletal muscle. J. Neuropath. Exp. Neurol. 56: 1283-1289 [Medline].
28. Feron, O., L. Belhassen, L. Kobzik, T. W. Smith, R. A. Kelly, and T. Michel. 1996. Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 27: 22810-22814 .
29.
Venema, V. J.,
H. Ju,
R. Zou, and
R. C. Venema.
1997.
Interaction of neuronal nitric oxide synthase with cavaeolin-3 in skeletal muscle.
J. Biol.
Chem.
272:
28187-28190
This article has been cited by other articles:
![]() |
T. Vassilakopoulos and S. N. A. Hussain Ventilatory muscle activation and inflammation: cytokines, reactive oxygen species, and nitric oxide J Appl Physiol, April 1, 2007; 102(4): 1687 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vassilakopoulos, K. Govindaraju, D. Parthenis, D. H. Eidelman, Y. Watanabe, and S. N. A. Hussain Nitric oxide production in the ventilatory muscles in response to acute resistive loading Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L1013 - L1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-D. Lajoix, S. Badiou, S. Peraldi-Roux, T. Chardes, S. Dietz, C. Aknin, F. Tribillac, P. Petit, and R. Gross Protein Inhibitor of Neuronal Nitric Oxide Synthase (PIN) Is a New Regulator of Glucose-Induced Insulin Secretion Diabetes, December 1, 2006; 55(12): 3279 - 3288. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.R. Magee, M.G. Ferrini, H.H. Davila, C.B. Zeller, D. Vernet, J. Sun, R. Lalani, A.L. Burnett, J. Rajfer, and N.F. Gonzalez-Cadavid Protein Inhibitor of Nitric Oxide Synthase (NOS) and the N-Methyl-D-Aspartate Receptor Are Expressed in the Rat and Mouse Penile Nerves and Colocalize with Penile Neuronal NOS Biol Reprod, February 1, 2003; 68(2): 478 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Stamler and G. Meissner Physiology of Nitric Oxide in Skeletal Muscle Physiol Rev, January 1, 2001; 81(1): 209 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M A Heunks and P N R. Dekhuijzen Respiratory muscle function and free radicals: from cell to COPD Thorax, August 1, 2000; 55(8): 704 - 716. [Full Text] |
||||
![]() |
A. Roczniak, D. Z. Levine, and K. D. Burns Localization of protein inhibitor of neuronal nitric oxide synthase in rat kidney Am J Physiol Renal Physiol, May 1, 2000; 278(5): F702 - F707. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |